Rishab Gupta

454 total citations
15 papers, 282 citations indexed

About

Rishab Gupta is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Economics and Econometrics. According to data from OpenAlex, Rishab Gupta has authored 15 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Genetics and 3 papers in Economics and Econometrics. Recurrent topics in Rishab Gupta's work include Diabetes Treatment and Management (9 papers), Diabetes Management and Research (9 papers) and Diabetes and associated disorders (3 papers). Rishab Gupta is often cited by papers focused on Diabetes Treatment and Management (9 papers), Diabetes Management and Research (9 papers) and Diabetes and associated disorders (3 papers). Rishab Gupta collaborates with scholars based in United States, France and United Kingdom. Rishab Gupta's co-authors include Timothy S. Bailey, Lawrence Blonde, Fang Liz Zhou, Jukka Westerbacka, Paulos Berhanu, Sean D. Sullivan, Ronald Preblick, Zsolt Bosnyák, Jennifer Sung and Fen Ye and has published in prestigious journals such as Diabetes, The American Journal of Cardiology and Diabetes Obesity and Metabolism.

In The Last Decade

Rishab Gupta

14 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rishab Gupta United States 10 209 87 56 40 24 15 282
Saud Alsifri Saudi Arabia 9 336 1.6× 122 1.4× 137 2.4× 29 0.7× 18 0.8× 26 398
Annie Nikolajsen Denmark 10 332 1.6× 82 0.9× 52 0.9× 54 1.4× 4 0.2× 18 369
S Roze France 13 360 1.7× 139 1.6× 121 2.2× 20 0.5× 63 2.6× 43 452
Yang Wen-ying China 5 230 1.1× 40 0.5× 38 0.7× 53 1.3× 24 1.0× 9 329
Ronald M. Krauss United States 4 63 0.3× 60 0.7× 38 0.7× 23 0.6× 55 2.3× 4 181
P Rys Poland 10 222 1.1× 95 1.1× 69 1.2× 30 0.8× 8 0.3× 22 324
Greg Lyubomirsky Australia 9 126 0.6× 57 0.7× 13 0.2× 26 0.7× 38 1.6× 12 234
Alberto Ramos Brazil 6 130 0.6× 25 0.3× 31 0.6× 9 0.2× 9 0.4× 7 210
Juan Manuel Toro Colombia 5 223 1.1× 38 0.4× 36 0.6× 33 0.8× 32 1.3× 14 259
Chunshen Pan United States 11 282 1.3× 33 0.4× 31 0.6× 43 1.1× 9 0.4× 20 328

Countries citing papers authored by Rishab Gupta

Since Specialization
Citations

This map shows the geographic impact of Rishab Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rishab Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rishab Gupta more than expected).

Fields of papers citing papers by Rishab Gupta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rishab Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rishab Gupta. The network helps show where Rishab Gupta may publish in the future.

Co-authorship network of co-authors of Rishab Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Rishab Gupta. A scholar is included among the top collaborators of Rishab Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rishab Gupta. Rishab Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gupta, Rishab, et al.. (2024). Predicting disease onset from electronic health records for population health management: a scalable and explainable Deep Learning approach. Frontiers in Artificial Intelligence. 6. 1287541–1287541. 10 indexed citations
2.
3.
4.
Bailey, Timothy S., Jasmanda Wu, Fang Liz Zhou, et al.. (2019). Switching to insulin glargine 300 units/mL in real‐world older patients with type 2 diabetes (DELIVER 3). Diabetes Obesity and Metabolism. 21(11). 2384–2393. 24 indexed citations
5.
Bailey, Timothy S., Fang Liz Zhou, Rishab Gupta, et al.. (2019). Glycaemic goal attainment and hypoglycaemia outcomes in type 2 diabetes patients initiating insulin glargine 300 units/mL or 100 units/mL: Real‐world results from the DELIVER Naïve cohort study. Diabetes Obesity and Metabolism. 21(7). 1596–1605. 26 indexed citations
6.
Sullivan, Sean D., Rishab Gupta, Jasmanda Wu, et al.. (2019). Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real‐world study. Diabetes Obesity and Metabolism. 21(9). 2123–2132. 23 indexed citations
7.
8.
Lee, Young‐Seok, Rishab Gupta, Jeong Taik Kwon, et al.. (2018). Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model. The Spine Journal. 18(10). 1877–1887. 11 indexed citations
9.
Karalis, Dean G., Usha G. Mallya, Ameen Ghannam, et al.. (2018). Prescribing Patterns of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in Eligible Patients With Clinical Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia. The American Journal of Cardiology. 121(10). 1155–1161. 24 indexed citations
10.
11.
12.
Khetan, Aditya, et al.. (2017). Prevalence and pattern of cardiovascular risk factors in a population in India. Heart Asia. 9(2). e010931–e010931. 12 indexed citations
13.
14.
Boklage, Susan, et al.. (2017). Abstract 203: Gender Differences in PCSK9 Inhibitor Prescribing. Circulation Cardiovascular Quality and Outcomes. 10(suppl_3). 1 indexed citations
15.
Zhou, Fang Liz, Fen Ye, Paulos Berhanu, et al.. (2017). Real‐world evidence concerning clinical and economic outcomes of switching to insulin glargine 300 units/mL vs other basal insulins in patients with type 2 diabetes using basal insulin. Diabetes Obesity and Metabolism. 20(5). 1293–1297. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saud Alsifri Breakdown of academic impact, for papers by Annie Nikolajsen Breakdown of academic impact, for papers by S Roze Breakdown of academic impact, for papers by Yang Wen-ying Breakdown of academic impact, for papers by Ronald M. Krauss Breakdown of academic impact, for papers by P Rys Breakdown of academic impact, for papers by Greg Lyubomirsky Breakdown of academic impact, for papers by Alberto Ramos Breakdown of academic impact, for papers by Juan Manuel Toro Breakdown of academic impact, for papers by Chunshen Pan
Rankless by CCL
2026